Libra Infusions Limited announcements
229 Dhaka Stock Exchange announcements for Libra Infusions Limited (LIBRAINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (8).
- High Court Directive to ensure financial support for Libra Infusions
The company has informed that the Honorable High Court has issued a Rule Nisi instructing Al-Arafah Islami Bank PLC. to provide all forms of financial assistance to Libra Infusions Limited in accordance with the agreement executed between them. As a result of this directive, there will no longer be any shortfall in the working capital of Libra Infusions Limited. Consequently, there are no longer any obstacle to full-scale production.
- Regarding clarification on recent post published in Facebook
Dhaka Stock Exchange PLC. asked for clarification from the company vide a letter dated November 19, 2024, regarding recent news published in a public group at Facebook regarding electricity and gas line cut-off as well as the status of production of the factory. In response, the Company Secretary has informed DSE, among others, the following: "I am writing to express my concern regarding news published in a public group at Face book on 18-11-2024. (cont.) (cont. news of LIBRAINFU): I believe the Face book news contains incorrect or misleading information. This information is not only factually incorrect but could also mislead our Stakeholders. The Face book news inaccurately stated that our Gas and Electricity line disconnected that was not true. However due to insufficient Working Capital our expected production level downward." (end)
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.85 for July-September 2021 as against Tk. 0.71 for July-September 2020. NOCFPS was Tk. 4.32 for July-September 2021 as against Tk. 6.75 for July-September 2020. NAV per share was Tk. 840.00 as on September 30, 2021 and Tk. 1,262.00 as on September 30, 2020.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 1.78 for October-December 2021 as against Tk. (1.48) for October-December 2020; EPS was Tk. 2.63 for July-December 2021 as against Tk. (0.75) for July-December 2020. NOCFPS was Tk. 5.63 for July-December 2021 as against Tk. 9.70 for July-December 2020. NAV per share was Tk. 842.00 as on December 31, 2021 and Tk. 1,261.00 as on June 30, 2021.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 1.37 for January-March 2022 as against Tk. (5.69) for January-March 2021; EPS was Tk. 4.00 for July 2021-March 2022 as against Tk. (6.44) for July 2020-March 2021. NOCFPS was Tk. 9.53 for July 2021-March 2022 as against Tk. 4.59 for July 2020-March 2021. NAV per share was Tk. 843.00 as on March 31, 2022 and Tk. 1,261.00 as on June 30, 2021.
- Dividend Disbursement
The company has informed that it has credited the Bonus Shares to the respective shareholders' BO Accounts and it has also disbursed the Cash Dividend to the respective shareholders for the year ended June 30, 2021.
- Category Change
The Company will be placed in 'Z' category from existing 'B' category with effect from September 26, 2024 as per provision 1(e) of BSEC Order No. BSEC/CMRRCD/2009-193/77, dated May 20, 2024.
- Prohibition on providing loan facilities to purchase securities
The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Libra Infusions Limited with effect from September 26, 2024 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.